Paul Croarkin, D.O., M.S., hosted a research panel at the American Academy of Childhood and Adolescent Psychiatry meeting in San Franisico this week. He and his fellow presenters are looking for an objective measure to gauge how well chemicals and other therapies are working in the barin. He’s looking for a definitive change, also known as a biomarker, in the brain.
The chemicals in the brain that will show whether a therapy is working are called the GABA and glutamate neurotransmitters. After administering a therapy such as stimulation of the brain with a non-invasive magnet called, repetitive transcranial magnetic stimulation — Croarkin and other researchers believe they will be able to prove the efficacy of many therapies by measuring the levels of these substances. See what he has to say in the YouTube video above.
